Meticulous Research® in its latest publication on Allergy Diagnostics Market states that the global allergy diagnostics market will increase at a CAGR of around 11.1% from 2019 to 2025 to reach $7.08 billion by 2025. Allergic diseases are affecting the lives of more than one billion people worldwide. More than 50 million Americans have experienced various types of allergies each year (Source: CDC). According to American College of Allergy, Asthma, and Immunology (ACAAI), allergies are the 6th leading cause of chronic illness in the U.S and annual cost of allergies exceeds $18 billion.
Analysis of Market Segments
The allergy diagnostics market is segmented by product & service (Assay Kits, Instruments, Services), by test (In Vivo Tests, and In Vitro Tests), by allergen (inhaled allergens, food allergens, drug allergens, and others), by end-user (diagnostic laboratories, hospital-based laboratories, academic research institutes and others), and by region.
On the basis of product & service, the allergy diagnostics market is segmented into Assay Kits, Instruments, and Services. Assay kits accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to widespread availability, lower cost, and significant consumption of assay kits in allergy testing.
Based on allergen type, the global allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2018, inhaled allergens accounted for the largest share of the global allergy diagnostics market. The large share of this segment is mainly due to increasing environmental pollution across the globe.
Based on end-user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and others. Diagnostic laboratories dominated the global allergy diagnostics market in 2018. The large share and high growth of this segment is attributed to increasing number of diagnostic centers, improving diagnostic lab infrastructure in developing countries, and greater preference to conduct these tests at these centers.
This research report analyzes major geographies and provides comprehensive value and volume analysis of North America (U.S., Canada), Europe (Germany, U.K., Spain, France, Italy, and RoE), Asia-Pacific (China, India, Japan, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for largest share of the global allergy diagnostics market. However, APAC is expected to register highest growth during the forecast period. The high growth of this region is mainly attributed to rise in number of hospitals and diagnostic laboratories, large patient pool, increasing awareness of allergy diseases, and growing healthcare expenditure.
Click here to: Get Free Request Sample Pages of this Report
Key Players
The report includes the competitive landscape based on an extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years. Biomérieux SA (France), Hitachi Chemical Co., Ltd. (Japan), Hob Biotech Group Suzhou Co., Ltd. (China), Hycor Biomedical, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Omega Diagnostics Group PLC (U.K.), R-Biopharm AG (Germany), Stallergenes Greer (U.K.), Siemens AG (Germany), and Thermo Fisher Scientific Inc. (U.S.) are the key players operating in this market. The players are adopting various organic and inorganic growth strategies in order to strengthen their presence and customer base.
Market Segmentation:
Allergy Diagnostics Market, By Product & Service
Allergy Diagnostics Market, By Test
Allergy Diagnostics Market, By Allergen
Allergy Diagnostics Market, By End User
Allergy Diagnostics Market, By Region/Country
Key questions answered in the report:
Growing penetration of allergy diagnostic tests in developing countries will propel the overall allergy diagnostics market
Diagnostic laboratories accounted for the largest share of the allergy diagnostics market globally
Allergy diagnostics market favours both larger and local manufacturers that compete in multiple segments
Recent partnerships, acquisitions, and expansions have taken place in the global allergy diagnostics market
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Estimation
3 Executive Summary
4 Market Insights
4.1 Introduction
4.2 Drivers
4.2.1 Rising Environmental Pollution Levels
4.2.2 High Incidence and Large Economic Burden of Allergic Diseases
4.2.3 Technological Advancements
4.2.4 Improving Coverage for Allergy Diagnosis
4.3 Restraints
4.3.1 Lack of awareness of Allergic Diseases
4.3.2 Issues Related to the Affordability of Allergy Diagnostics Instruments Among Small
Laboratories and Physician Clinics
4.4 Opportunities
4.4.1 Emerging Markets
5 Global Allergy Diagnostics Market, by Product & Service
5.1 Introduction
5.2 Assay Kits
5.3 Instruments
5.3.1 Immunoassay Analyzers
5.3.2 Luminometers
5.3.3 ELISA Analyzers
5.3.4 Other Instruments
5.4 Services
6 Global Allergy Diagnostics Market, By Test
6.1 Introduction
6.2 In Vitro Tests
6.3 In Vivo Tests
7 Global Allergy Diagnostics Market, By Allergen
7.1 Introduction
7.2 Inhaled Allergens
7.3 Food Allergens
7.4 Drug Allergens
7.5 Other Allergens
10 Global Allergy Diagnostics Market, By End User
10.1 Introduction
10.2 Diagnostic Laboratories
10.3 Hospital-Based Laboratories
10.4 Academic Research Institutes
10.5 Other End Users
11 Global Allergy Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 RoE
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 RoAPAC
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East & Africa
12 Competitive Landscape
12.1 Introduction
12.2 Company Benchmarking
12.3 Market Share Analysis
13 Company Profiles
13.1 Biomérieux SA
13.1.1 Business Overview
13.1.2 Financial Portfolio
13.1.3 Product Portfolio
13.1.4 Strategic Developments
13.2 Hitachi Chemical Co., Ltd.
13.2.1 Business Overview
13.2.2 Financial Portfolio
13.2.3 Product Portfolio
13.2.4 Strategic Developments
13.3 Hob Biotech Group Suzhou Co., Ltd.
13.3.1 Business Overview
13.3.2 Financial Portfolio
13.3.3 Product Portfolio
13.3.4 Strategic Developments
13.4 Hycor Biomedical, Inc.
13.4.1 Business Overview
13.4.2 Financial Portfolio
13.4.3 Product Portfolio
13.4.4 Strategic Developments
13.5 Lincoln Diagnostics, Inc.
13.5.1 Business Overview
13.5.2 Financial Portfolio
13.5.3 Product Portfolio
13.5.4 Strategic Developments
13.6 Omega Diagnostics Group PLC
13.6.1 Business Overview
13.6.2 Financial Portfolio
13.6.3 Product Portfolio
13.6.4 Strategic Developments
13.7 R-Biopharm AG
13.7.1 Business Overview
13.7.2 Financial Portfolio
13.7.3 Product Portfolio
13.7.4 Strategic Developments
13.8 Stallergenes Greer
13.8.1 Business Overview
13.8.2 Financial Portfolio
13.8.3 Product Portfolio
13.8.4 Strategic Developments
13.9 Siemens AG
13.9.1 Business Overview
13.9.2 Financial Portfolio
13.9.3 Product Portfolio
13.9.4 Strategic Developments
13.10 Thermo Fisher Scientific Inc.
13.10.1 Business Overview
13.10.2 Financial Portfolio
13.10.3 Product Portfolio
13.10.4 Strategic Developments
14 Appendix
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
Published Date: Jan-2023
Published Date: Oct-2022
Published Date: Jun-2022
